This event investigates this complicated disease and how today’s remote monitoring solutions measure up to existing diabetes indications and established care pathways. We identify what technical challenges remain to be solved and discuss how pathways can unite towards an improved care, lower cost, connected future.
The information supplied below may be subject to change before the event.
Registration and networking with lunch
Introduction to Healthcare from Paul Winter, TTP Group
Welcome from event supporter, Dr Hans Hagen, Cambridge University Health Partners
Diabetes in the 21st century; still exploring uncharted seas; Dr Tony Coll, Wellcome Trust-MRC Institute of Metabolic Science
The principle of overcoming a hormone deficiency with replacement therapy is a simple one and remains at the heart of diabetes care. However, to do this safely over a long period of time remains difficult for many patients. In particular, there remains the challenge of balancing the avoidance of long term complications of poor glucose control with the need to minimise iatrogenic harm from therapies. In trying to tackle these problems, the diabetes community has always been a ready embracer of technology, both in terms of drug delivery apparatus and biochemical monitoring systems. In this session, I will give a brief overview of both type 1 and type 2 diabetes mellitus and consider some of the medical and financial issues that diabetes care continues to face.
Remote Continuous Glucose Monitoring (CGM); Melissa Holloway, INPUT Patient Advocacy and Speaking Diabetes Ltd
This talk will provide a whirlwind overview of current diabetes technologies that allow for remote data access, including continuous glucose monitoring, flash glucose monitoring, blood glucose meters with Bluetooth, and cloud-based diabetes data management systems.
Be all you can be, Always! - integrated mobile connected hardware and software as a service to improve quality of life for people with diabetes; Henrik Norström, Brighter
Brighter has sought to use state of the art technological solutions - such as blood sugar monitors and insulin pens - for diabetes care integrated into a single device, logging the data and transmitting this through a global mobile connection to its platform to close the loop to the different stakeholders in the care chain. With the patients at the epicentre, enabling a higher motivation to adhere to the treatment, we also create the opportunity to empower the patients in relation to the medical condition and the costs. Adherence is low, costs of complications are high. By reducing barriers to effective direct care, adherence should increase and costs of complications should be reduced, resulting in a lower lifecycle cost and high quality of life - Be all you can be, Always!
Refreshments and networking
Artificial pancreas – the next step in connectivity and digital treatment of type 1 diabetes; Dr Roman Hovorka, University of Cambridge Metabolic Research Lab
Rapid progress over the past decade has been made with the development of the ‘Artificial Pancreas’, also known as the closed-loop system, which emulates the feedback glucose-responsive functionality of the pancreatic beta cell. The recent FDA approval of the first hybrid closed-loop system makes the Artificial Pancreas a realistic therapeutic option for people with type 1 diabetes. The introduction of the artificial pancreas into clinical practice represents a milestone towards the goal of improving the care of people with type 1 diabetes. There remains a need to understand the impact of the technology, its data remote monitoring capabilities, and implication on current diabetes management and care.
Disrupting the diabetes integrated care pathway; Dr Sufyan Hussein, Royal Free Hospitals Trust
This talk reviews the current response ecosystem and how technology advancements, integration and data analysis may better support stakeholders and impact care pathways
Panel session with all speakers chaired by SIG Champion, Paul Winter, TTP Extra Panellist - Stuart Stafford, AstraZeneca
Dr Tony Coll - University Lecturer/Honorary Consultant Physician, Wellcome Trust
Melissa Holloway - , Input
Roman Hovorka - Director of Research, University of Cambridge Metabolic Research Lab
Sufyan Hussein - Consultant, Royal Free Hospitals Trust
Henrik Norström - COO, Brighter
Stuart Stafford - Functional Project Manager, AstraZeneca
Leila Ali - Founder, Digital Health Cambridge
Leila is passionate about applying innovative approaches in bridging the worlds between health and technology. She has worked in the health sector for over 10 years and has a deep understanding of the importance of identifying opportunities of engagement and the evolving needs of patients.
During Covid-19 she has been exploring digital health solutions at Addenbrooke's Hospital on safely connecting patients to families.
Leila is the founder and organiser of Digital Health Cambridge, a meet-up group that brings together various stakeholders, clinicians, investors and startups in Cambridge to foster a multi - stakeholder partnership. She is currently an eHospital support link at Cambridge University Hospitals NHS Foundation Trust, where she trains and supports colleagues regarding best practice using Epic (electronic patient record system). A digital strategy which enables clinicians to use the latest in computer technology to help them to consistently provide high quality patient care.
Peter Ferguson - Director for Healthcare Technologies, Arm
Peter is director for healthcare technologies at Arm and has been actively involved in the delivery of mobile and healthcare solutions since starting his Medical Electronics PhD in 1994. Based in Cambridge, UK, Peter is responsible for driving Arm's health strategies in Medical Sensors and Genomics. His remit is helping the healthcare industry to utilize Arm's high efficiency technology in developing new products and services. Peter has more than 20 years' experience working in the healthcare, mobile tech and pharmaceutical technology market and has been instrumental in delivering innovative mobile health solutions including wearable ECG, Mobile Devices, Adverse Event Systems and Portal Hospital solutions in the UK and China.
Siddhi Trivedi - Founder, Beyond Identity
Siddhi’s ambition is to build an inclusive community with a focus on social innovation through the intersection between emerging technologies and creative minds.
Siddhi specialises in strategic, operational and technology-enabled business transformation. She founded Beyond Identity, to implement digital tools through the application of IOT, AI and blockchain enabled solutions. She has deep insight into developing apps and platforms, and regularly speaks about innovations within the healthcare sector at international conferences. Since the advent of COVID-19, she has been working with medical clinicians within Oxfordshire to develop an app to empower patients to manage their health.
She is a healthcare SIG champion for Cambridge Wireless and a lead organiser for Tech London Advocates Blockchain Group a think tank and repository for knowledge sharing and to position London as a global leader in blockchain advocacy.
As a champion for women and girls in tech, Siddhi founded project BIBA, a platform designed to connect girls and women with live projects with tech companies who are keen to bridge the gender gap in their organisations. This project has been supported and born out London Tech week in September 2020 and will officially launch at London Tech Week in September 2021.
Nigel Whittle - VP, Medical & Healthcare, Plextek
Nigel is Head of Medical & Healthcare at Plextek, spearheading engagement with a range of clients in the medical device sector, helping them develop innovative technology around sensors, data collection, communications and related areas. Nigel has over 25 years’ experience in the global life science industry, in a wide range of senior scientific, commercial and managerial roles. He conducted research work at Genentech and Celltech, then at Cantab Pharmaceuticals he was responsible for all company product development, taking proprietary products into late-stage Clinical Trials. With the IP Group he established a programme of technology commercialisation from Kings College London, including start up and flotation of companies. Later, working for UK Trade & Investment, Nigel worked with a portfolio of overseas pharmaceutical companies to secure high-level investment into the UK’s R&D capabilities. More recently he has worked as a business consultant both as an independent and at Sagentia. His current interests include the development of wearable technology to support clinical studies, and the use of monitoring systems for assisted living.
Paul Winter - Senior RF Consultant, TTP plc
Paul Winter is a programme manager and RF engineer in the Communications and Wireless group at TTP. He has led numerous projects in commercial, industrial and healthcare sectors developing connected devices and precision instrumentation. Paul has a heritage in developing products integrating multiple wireless standards including GPS, GPRS, Wi-Fi, Bluetooth and proprietary ISM band radios, deployed within multi-sensor systems for in-home and on-body applications, often coupled to 'Cloud' based analysis and visualisation services. In healthcare Paul has applied aspects of wireless, antennas and electronics to a number of medical devices including inhalers, glucose testing and point of care diagnostic instruments. Paul has also led several incubation projects for TTP's Carbon Trust Incubator, covering a wide range of cutting edge technologies. Paul joined TTP in 2006; prior to this he worked as a radio engineer for Global Communications developing high volume consumer in-home satellite and digital TV distribution equipment, as well as portable equipment for the 'on-location' broadcasting industry. Paul has a Masters degree in Electrical & Electronic Engineering from the University of Wales, Cardiff. He is a member of the Institute of Engineering and Technology, the Royal Academy of Engineering and is a Charted Engineer.
Event LocationOpen in google maps
William Harvey Lecture Theatre, School of Clinical Medicine, Addenbrooke's Hospital Cambridge, CB2 0SP
Disrupting the diabetes integrated care pathway
Presented by Sufyan Hussein , Imperial College at Unlocking 'remote monitoring' for effective diabetes care
Remote Continuous Glucose Monitoring (CGM)
Presented by Melissa Holloway, Input at Unlocking 'remote monitoring' for effective diabetes care
Artificial pancreas – the next step in connectivity and digital treatment of type 1 diabetes
Presented by Dr Roman Havorka , University of Cambridge at Unlocking 'remote monitoring' for effective diabetes care